NR 567 Advanced Pharmacology Midterm Exam |
Latest Update 2026/2027 | 200 Practice Questions &
Detailed Answers | Grade A Study Guide | A+ Graded
SECTION 1: PHARMACOKINETICS (Questions 1–30)
1. A drug with a high firstpass effect is administered orally. Where is it primarily metabolized before
reaching systemic circulation?
A. Kidneys
B. Lungs
C. Liver
D. Stomach
Correct Answer: C
Rationale: Firstpass metabolism occurs in the liver. Kidneys excrete drugs, lungs metabolize some drugs
but not primary firstpass, and the stomach absorbs but does not significantly metabolize.
2. A patient receives a drug with a halflife of 4 hours. Approximately how many hours will it take to
reach steady state?
A. 8 hours
B. 12 hours
C. 20 hours
D. 40 hours
Correct Answer: C
,Rationale: Steady state is reached in 4–5 halflives (20 hours for 5 halflives). 8 hours is 2 halflives, 12
hours is 3 halflives, and 40 hours is 10 halflives.
3. Which of the following IS NOT a primary pharmacokinetic parameter?
A. Bioavailability
B. Volume of distribution
C. Clearance
D. Receptor affinity
Correct Answer: D
Rationale: Receptor affinity is a pharmacodynamic parameter, not pharmacokinetic. Bioavailability,
volume of distribution, and clearance are primary pharmacokinetic parameters.
4. A drug with a narrow therapeutic index requires:
A. No monitoring
B. Routine therapeutic drug monitoring
C. Higher doses
D. Shorter dosing intervals
Correct Answer: B
Rationale: Drugs with a narrow therapeutic index (e.g., lithium, warfarin, digoxin) require routine
therapeutic drug monitoring to prevent toxicity.
,5. Which route of administration bypasses firstpass metabolism?
A. Oral
B. Rectal
C. Intravenous
D. Sublingual
Correct Answer: C
Rationale: Intravenous administration bypasses firstpass metabolism entirely, delivering the drug
directly into systemic circulation. Sublingual and rectal partially bypass firstpass.
6. The volume of distribution (Vd) of a drug reflects:
A. The rate of drug elimination
B. The extent of drug distribution into body tissues
C. The speed of drug absorption
D. The degree of protein binding
Correct Answer: B
Rationale: Volume of distribution reflects the extent of drug distribution into body tissues relative to
plasma. A high Vd indicates extensive tissue distribution.
7. Which factor would most likely increase the halflife of a drug?
, A. Increased hepatic blood flow
B. Decreased renal function
C. Increased enzyme induction
D. Decreased protein binding
Correct Answer: B
Rationale: Decreased renal function reduces drug clearance, prolonging halflife. Increased hepatic blood
flow and enzyme induction decrease halflife.
8. A patient with hypoalbuminemia is at increased risk for:
A. Decreased drug effect
B. Increased free drug concentration and toxicity
C. Faster drug elimination
D. Reduced drug absorption
Correct Answer: B
Rationale: Albumin is the primary drugbinding protein. Hypoalbuminemia increases free (unbound) drug
concentration, potentially causing toxicity.
9. Which statement about bioavailability is correct?
A. IV administration has 100% bioavailability
B. Oral administration always has 100% bioavailability
C. Bioavailability is the same for all routes
Latest Update 2026/2027 | 200 Practice Questions &
Detailed Answers | Grade A Study Guide | A+ Graded
SECTION 1: PHARMACOKINETICS (Questions 1–30)
1. A drug with a high firstpass effect is administered orally. Where is it primarily metabolized before
reaching systemic circulation?
A. Kidneys
B. Lungs
C. Liver
D. Stomach
Correct Answer: C
Rationale: Firstpass metabolism occurs in the liver. Kidneys excrete drugs, lungs metabolize some drugs
but not primary firstpass, and the stomach absorbs but does not significantly metabolize.
2. A patient receives a drug with a halflife of 4 hours. Approximately how many hours will it take to
reach steady state?
A. 8 hours
B. 12 hours
C. 20 hours
D. 40 hours
Correct Answer: C
,Rationale: Steady state is reached in 4–5 halflives (20 hours for 5 halflives). 8 hours is 2 halflives, 12
hours is 3 halflives, and 40 hours is 10 halflives.
3. Which of the following IS NOT a primary pharmacokinetic parameter?
A. Bioavailability
B. Volume of distribution
C. Clearance
D. Receptor affinity
Correct Answer: D
Rationale: Receptor affinity is a pharmacodynamic parameter, not pharmacokinetic. Bioavailability,
volume of distribution, and clearance are primary pharmacokinetic parameters.
4. A drug with a narrow therapeutic index requires:
A. No monitoring
B. Routine therapeutic drug monitoring
C. Higher doses
D. Shorter dosing intervals
Correct Answer: B
Rationale: Drugs with a narrow therapeutic index (e.g., lithium, warfarin, digoxin) require routine
therapeutic drug monitoring to prevent toxicity.
,5. Which route of administration bypasses firstpass metabolism?
A. Oral
B. Rectal
C. Intravenous
D. Sublingual
Correct Answer: C
Rationale: Intravenous administration bypasses firstpass metabolism entirely, delivering the drug
directly into systemic circulation. Sublingual and rectal partially bypass firstpass.
6. The volume of distribution (Vd) of a drug reflects:
A. The rate of drug elimination
B. The extent of drug distribution into body tissues
C. The speed of drug absorption
D. The degree of protein binding
Correct Answer: B
Rationale: Volume of distribution reflects the extent of drug distribution into body tissues relative to
plasma. A high Vd indicates extensive tissue distribution.
7. Which factor would most likely increase the halflife of a drug?
, A. Increased hepatic blood flow
B. Decreased renal function
C. Increased enzyme induction
D. Decreased protein binding
Correct Answer: B
Rationale: Decreased renal function reduces drug clearance, prolonging halflife. Increased hepatic blood
flow and enzyme induction decrease halflife.
8. A patient with hypoalbuminemia is at increased risk for:
A. Decreased drug effect
B. Increased free drug concentration and toxicity
C. Faster drug elimination
D. Reduced drug absorption
Correct Answer: B
Rationale: Albumin is the primary drugbinding protein. Hypoalbuminemia increases free (unbound) drug
concentration, potentially causing toxicity.
9. Which statement about bioavailability is correct?
A. IV administration has 100% bioavailability
B. Oral administration always has 100% bioavailability
C. Bioavailability is the same for all routes
